Neelapu, S. S., Chavez, J. C., Sehgal, A. R., Epperla, N., Ulrickson, M., Bachy, E., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Oluwole, O. O., Yakoub-Agha, I., Khanal, R., Rosenblatt, J., Korn, R., Peng, W., Lui, C., … Jacobson, C. A. (2024). Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5). Blood, 143(6), 496–506. https://doi.org/10.1182/blood.2023021243
Subjects:
Chimeric Antigen Receptor T Cell Therapy
(OpenAlex Topic)
Lymphoid Neoplasms
(OpenAlex Topic)
Natural Killer Cells in Immunity
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/blood.2023021243
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: